Drug Search Results
More Filters [+]

Prochlorperazine

Alternative Names: prochlorperazine, compazine, compro, procomp
Latest Update: 2024-08-07
Latest Update Note: Clinical Trial Update

Product Description

Prochlorperazine is used to treat nervous, emotional, and mental conditions (eg, schizophrenia) and non-psychotic anxiety. It is also used to control severe nausea and vomiting. This medicine should not be used to treat behavioral problems in older adult patients who have dementia. (Sourced from: https://www.mayoclinic.org/drugs-supplements/prochlorperazine-oral-route/side-effects/drg-20406263?p=1)

Mechanisms of Action: D2 Antagonist

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: Intravenous,Oral,Inhalant

FDA Designation: None *

Approval Status: Approved

Approved Countries: Australia | Bangladesh | Canada | Cyprus | Egypt | Finland | Hong Kong | India | Ireland | Italy | Lebanon | Malaysia | Malta | New Zealand | Norway | Pakistan | Peru | Philippines | Poland | Romania | Singapore | South Africa | Sri Lanka | Sweden | Taiwan | Ukraine | United Kingdom | United States | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Prochlorperazine

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events